These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 28107445)

  • 1. Beta-Glucans Supplementation Associates with Reduction in P-Cresyl Sulfate Levels and Improved Endothelial Vascular Reactivity in Healthy Individuals.
    Cosola C; De Angelis M; Rocchetti MT; Montemurno E; Maranzano V; Dalfino G; Manno C; Zito A; Gesualdo M; Ciccone MM; Gobbetti M; Gesualdo L
    PLoS One; 2017; 12(1):e0169635. PubMed ID: 28107445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations in gut microbiota composition and metabolic parameters after dietary intervention with barley beta glucans in patients with high risk for metabolic syndrome development.
    Velikonja A; Lipoglavšek L; Zorec M; Orel R; Avguštin G
    Anaerobe; 2019 Feb; 55():67-77. PubMed ID: 30396006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary protein-fiber ratio associates with circulating levels of indoxyl sulfate and p-cresyl sulfate in chronic kidney disease patients.
    Rossi M; Johnson DW; Xu H; Carrero JJ; Pascoe E; French C; Campbell KL
    Nutr Metab Cardiovasc Dis; 2015 Sep; 25(9):860-865. PubMed ID: 26026209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microbiome perturbation by oral vancomycin reduces plasma concentration of two gut-derived uremic solutes, indoxyl sulfate and p-cresyl sulfate, in end-stage renal disease.
    Nazzal L; Roberts J; Singh P; Jhawar S; Matalon A; Gao Z; Holzman R; Liebes L; Blaser MJ; Lowenstein J
    Nephrol Dial Transplant; 2017 Nov; 32(11):1809-1817. PubMed ID: 28379433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased p-cresyl sulfate level is independently associated with poor outcomes in patients with heart failure.
    Wang CH; Cheng ML; Liu MH; Shiao MS; Hsu KH; Huang YY; Lin CC; Lin JF
    Heart Vessels; 2016 Jul; 31(7):1100-8. PubMed ID: 26135926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does Low-Protein Diet Influence the Uremic Toxin Serum Levels From the Gut Microbiota in Nondialysis Chronic Kidney Disease Patients?
    Black AP; Anjos JS; Cardozo L; Carmo FL; Dolenga CJ; Nakao LS; de Carvalho Ferreira D; Rosado A; Carraro Eduardo JC; Mafra D
    J Ren Nutr; 2018 May; 28(3):208-214. PubMed ID: 29439931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Can curcumin supplementation reduce plasma levels of gut-derived uremic toxins in hemodialysis patients? A pilot randomized, double-blind, controlled study.
    Salarolli RT; Alvarenga L; Cardozo LFMF; Teixeira KTR; de S G Moreira L; Lima JD; Rodrigues SD; Nakao LS; Fouque D; Mafra D
    Int Urol Nephrol; 2021 Jun; 53(6):1231-1238. PubMed ID: 33438085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial.
    Rossi M; Johnson DW; Morrison M; Pascoe EM; Coombes JS; Forbes JM; Szeto CC; McWhinney BC; Ungerer JP; Campbell KL
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):223-31. PubMed ID: 26772193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. LC-MS/MS method for simultaneous determination of serum p-cresyl sulfate and indoxyl sulfate in patients undergoing peritoneal dialysis.
    Shu C; Chen X; Xia T; Zhang F; Gao S; Chen W
    Biomed Chromatogr; 2016 Nov; 30(11):1782-1788. PubMed ID: 27129599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uremic toxin development in living kidney donors: a longitudinal study.
    Rossi M; Campbell KL; Johnson DW; Stanton T; Haluska BA; Hawley CM; Dimeski G; McWhinney BC; Ungerer JP; Kaisar OM; Isbel NM
    Transplantation; 2014 Mar; 97(5):548-54. PubMed ID: 24162249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uraemic toxins and cardiovascular disease across the chronic kidney disease spectrum: an observational study.
    Rossi M; Campbell K; Johnson D; Stanton T; Pascoe E; Hawley C; Dimeski G; McWhinney B; Ungerer J; Isbel N
    Nutr Metab Cardiovasc Dis; 2014 Sep; 24(9):1035-42. PubMed ID: 24880738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Meta-Analysis of the Associations of p-Cresyl Sulfate (PCS) and Indoxyl Sulfate (IS) with Cardiovascular Events and All-Cause Mortality in Patients with Chronic Renal Failure.
    Lin CJ; Wu V; Wu PC; Wu CJ
    PLoS One; 2015; 10(7):e0132589. PubMed ID: 26173073
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Indoxyl sulfate, not P-cresyl sulfate, is associated with advanced glycation end products in patients on long-term hemodialysis.
    Lin CJ; Lin J; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ
    Kidney Blood Press Res; 2015; 40(2):121-9. PubMed ID: 25833743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of Divinylbenzenic Resin in Removing Indoxyl Sulfate and P-Cresol Sulfate in Hemodialysis Patients: Results From an In Vitro Study and An In Vivo Pilot Trial (xuanro4-Nature 3.2).
    Rocchetti MT; Cosola C; di Bari I; Magnani S; Galleggiante V; Scandiffio L; Dalfino G; Netti GS; Atti M; Corciulo R; Gesualdo L
    Toxins (Basel); 2020 Mar; 12(3):. PubMed ID: 32164382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolism, Protein Binding, and Renal Clearance of Microbiota-Derived p-Cresol in Patients with CKD.
    Poesen R; Evenepoel P; de Loor H; Kuypers D; Augustijns P; Meijers B
    Clin J Am Soc Nephrol; 2016 Jul; 11(7):1136-1144. PubMed ID: 27084876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gastrointestinal-related uremic toxins in peritoneal dialysis: a pilot study with a 5-year follow-up.
    Lin CJ; Pan CF; Chuang CK; Liu HL; Sun FJ; Wang TJ; Chen HH; Wu CJ
    Arch Med Res; 2013 Oct; 44(7):535-41. PubMed ID: 24055267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measuring serum total and free indoxyl sulfate and p-cresyl sulfate in chronic kidney disease using UPLC-MS/MS.
    Lin CN; Wu IW; Huang YF; Peng SY; Huang YC; Ning HC
    J Food Drug Anal; 2019 Apr; 27(2):502-509. PubMed ID: 30987721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic analysis of uremic toxins by liquid chromatography/electrospray ionization-tandem mass spectrometry.
    Kikuchi K; Itoh Y; Tateoka R; Ezawa A; Murakami K; Niwa T
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(20):1662-8. PubMed ID: 20036201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p-Cresol and Cardiovascular Risk in Kidney Transplant Recipients.
    Ligabue G; Damiano F; Cuoghi A; De Biasi S; Bellei E; Granito M; Aldo T; Cossarizza A; Cappelli G
    Transplant Proc; 2015 Sep; 47(7):2121-5. PubMed ID: 26361658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein-bound uremic toxins in hemodialysis patients measured by liquid chromatography/tandem mass spectrometry and their effects on endothelial ROS production.
    Itoh Y; Ezawa A; Kikuchi K; Tsuruta Y; Niwa T
    Anal Bioanal Chem; 2012 Jun; 403(7):1841-50. PubMed ID: 22447217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.